Inovio Total Assets from 2010 to 2024
| INO Stock | USD 4.19 0.18 4.49% |
Total Assets | First Reported 1998-12-31 | Previous Quarter 133.8 M | Current Value 107.1 B | Quarterly Volatility 10.5 B |
Check Inovio Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Inovio Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.4 M, Interest Expense of 1.2 M or Total Revenue of 790.4 K, as well as many indicators such as Price To Sales Ratio of 155, Dividend Yield of 1.0E-4 or PTB Ratio of 1.1. Inovio financial statements analysis is a perfect complement when working with Inovio Pharmaceuticals Valuation or Volatility modules.
Inovio | Total Assets |
Latest Inovio Pharmaceuticals' Total Assets Growth Pattern
Below is the plot of the Total Assets of Inovio Pharmaceuticals over the last few years. Total assets refers to the total amount of Inovio Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Inovio Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Inovio Pharmaceuticals' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Inovio Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 172.94 M | 10 Years Trend |
|
Total Assets |
| Timeline |
Inovio Total Assets Regression Statistics
| Arithmetic Mean | 191,623,295 | |
| Geometric Mean | 134,720,020 | |
| Coefficient Of Variation | 80.73 | |
| Mean Deviation | 110,879,326 | |
| Median | 143,951,597 | |
| Standard Deviation | 154,692,872 | |
| Sample Variance | 23929.9T | |
| Range | 530M | |
| R-Value | 0.59 | |
| Mean Square Error | 16813.7T | |
| R-Squared | 0.35 | |
| Significance | 0.02 | |
| Slope | 20,392,580 | |
| Total Sum of Squares | 335018.4T |
Inovio Total Assets History
Other Fundumenentals of Inovio Pharmaceuticals
Inovio Pharmaceuticals Total Assets component correlations
Click cells to compare fundamentals
About Inovio Pharmaceuticals Financial Statements
Inovio Pharmaceuticals investors utilize fundamental indicators, such as Total Assets, to predict how Inovio Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Total Assets | 172.9 M | 131.2 M | |
| Intangibles To Total Assets | 0.04 | 0.04 |
Check out the analysis of Inovio Pharmaceuticals Correlation against competitors. To learn how to invest in Inovio Stock, please use our How to Invest in Inovio Pharmaceuticals guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inovio Pharmaceuticals. If investors know Inovio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inovio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.43) | Revenue Per Share 0.025 | Quarterly Revenue Growth (0.55) | Return On Assets (0.40) | Return On Equity (0.91) |
The market value of Inovio Pharmaceuticals is measured differently than its book value, which is the value of Inovio that is recorded on the company's balance sheet. Investors also form their own opinion of Inovio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Inovio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inovio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Inovio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inovio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Inovio Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inovio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.